Hamps Bio Ltd

Hamps Bio Ltd has announced the closure of its trading window for all designated persons, directors, and their immediate relatives. This closure is in compliance with SEBI regulations and the company's insider trading code. The window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited standalone and consolidated financial results for the half-year ending September 30, 2026. The specific date of the board meeting to consider these results will be communicated later. Insiders are advised against trading company securities during this period.

Hamps Bio Ltd announced that its Board of Directors, during a meeting held on September 9, 2026, approved increases in remuneration for key management personnel. These approvals were made based on recommendations from the Nomination and Remuneration Committee. The individuals whose remuneration was adjusted include Mr. Herrik Mountbaton Shah (Chairman and Managing Director), Mr. Shrenikkumar Mountkumar Shah (Whole Time Director), and Mrs. Mitali Shrenikkumar Shah (Chief Financial Officer). Additionally, the Board approved the remuneration for Mrs. Pallavi Herrik Shah, a Director of the company.

Hamps Bio Ltd has submitted its Annual Report for the financial year 2025-26, as per SEBI regulations. The report, which includes the Notice of the 19th Annual General Meeting, has been sent to members electronically and is also available on the company's website. The filing details corporate information, board of directors, financial performance highlights, auditor reports, and product overview. The company's registered office is in Ankleshwar, Gujarat, with a corporate office in Surat.

Hamps Bio Limited has announced its 19th Annual General Meeting (AGM) to be held on September 9, 2026, at 12:00 PM at its registered office in Ankleshwar, Gujarat. The meeting agenda includes the adoption of audited standalone and consolidated financial statements for the fiscal year 2025-26, the re-appointment of Mrs. Pallavi Herrik Shah as a director, and a special business item to approve the shifting of the company's registered office from Bharuch, Ankleshwar to Surat, Gujarat. The notice also details proxy appointment rules for attending members.

Hamps Bio Ltd's Board of Directors met on August 12, 2026, approving the Board of Directors Report and the draft Annual Report for the financial year ended March 31, 2026. The board also approved the notice for the 19th Annual General Meeting (AGM) scheduled for September 9, 2026. Key decisions included recommending the re-appointment of Director Mrs. Pallavi Herrik Shah, proposing a shift of the registered office from Ankleshwar to Surat, and appointing M/s. Richa Goyal & Associates as Scrutinizer for the AGM. A cut-off date was also fixed for determining member eligibility for voting and attendance at the AGM.

Hamps Bio Ltd has filed an intimation under Regulation 30(5) of SEBI LODR to update the contact details of its Key Managerial Personnel (KMP). These individuals are authorized to determine the materiality of events and make disclosures to the stock exchanges. The updated contact information includes Mr. Herrik Mountbaton Shah (Managing Director), Mr. Shrenikkumar Mountkumar Shah (Whole-time Director), Mrs. Mitali Shrenikkumar Shah (Chief Financial Officer), and Mr. Ravi Baheti (Company Secretary & Compliance Officer). The company has also made this information available on its website, www.hampsbio.com.

Hamps Bio Ltd announced changes in its key management personnel following a Board Meeting held on July 6, 2026. Ms. Komal Jain resigned as Company Secretary & Compliance Officer, effective June 30, 2026, due to personal reasons. The Board approved the appointment of Mr. Ravi Baheti as her replacement, effective July 6, 2026. Mr. Baheti is an Associate Member of ICSI with over nine years of experience. The Board also authorized Key Managerial Personnel (KMPs) to determine the materiality of events for stock exchange disclosures.

Hamps Bio Limited has re-appointed M/s Naviwala & Associates, Surat, as its Internal Auditor for the Financial Year 2026-27, effective from May 29, 2026. This decision was made during the Board of Directors meeting held on May 29, 2026, and complies with Regulation 30 of the Listing Regulations. Naviwala and Associates, founded in July 2020, has expertise in India's financial landscape.

Hamps Bio Ltd's Board of Directors approved the standalone and consolidated audited financial results for the half year and financial year ended March 31, 2026. The board also took note of the auditor’s report with an unmodified opinion issued by M/s MGHVS & ASSOCIATES. Additionally, M/s Naviwala & Associates, Surat, were appointed as the Internal Auditor for the Financial Year 2026-2027.

Hamps Bio Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited standalone and consolidated financial results for the half year and year ended March 31, 2026. The board will also consider the appointment of Naviwala & Associates as internal auditor for the financial year 2026-2027.